Cardiac Valve Market Report 2026

Cardiac Valve Market Overview

• Cardiac Valve market size has reached to $12.41 billion in 2025 • Expected to grow to $24.02 billion in 2030 at a compound annual growth rate (CAGR) of 14% • Growth Driver: Cardiac Valve Market Expansion Addressing The Growing Burden Of Heart-Related Ailments • Market Trend: Adoption of Transfemoral Transcatheter Mitral Valve Replacement Systems in Cardiac Valve Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiac Valve Market?

Cardiac valves refer to artificial valves used to keep the flow of blood in one direction from the heart to the rest of the body parts. A cardiac valve is an implantable device used to replace a damaged body valve that has stopped working due to various diseases. The primary function of the cardiac valve is to keep blood flowing in the proper direction through the heart and from the heart into the major blood vessels connected to it. The main types of cardiac valves are tissue, transcatheter, mechanical, and other heart valves. Tissue heart valves refer to heart valves used in open heart or minimally invasive surgery to prevent blood clots inside the vessels. Animal tissue that is robust and flexible is used to make tissue valves from the valves of animal donors. These valves are used in cardiac valve repair and cardiac valve replacement. The aortic valve, mitral valve, and other positions where the cardiac valve is repaired or replaced in the heart. Hospitals and clinics, specialty centers, cardiac research institutes, and others are the end users of cardiac valves.

What Is The Cardiac Valve Market Growth Forecast?

The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $24.02 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to increasing demand for transcatheter interventions, rising focus on elderly cardiac care, expansion of hybrid cardiac procedures, growing investments in next-generation valve technologies, increasing adoption of patient-specific valve solutions. Major trends in the forecast period include increasing adoption of transcatheter valve procedures, rising demand for bioprosthetic heart valves, growing preference for minimally invasive valve replacement, expansion of advanced valve repair techniques, enhanced focus on valve durability and performance.

Global Cardiac Valve Market Segmentation

1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves 2) By Position: Aortic Valve, Mitral Valve, Other Positions 3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement 4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users Subsegments: 1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves 2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR / TAVI) Valves, Transcatheter Mitral Valve Replacement (TMVR) Valves 3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves

What Is The Driver Of The Cardiac Valve Market?

The rising incidence of cardiovascular diseases is expected to propel the growth of the cardiac valve market. The prevalence of cardiovascular disease has gradually increased due to smoking, obesity, a lack of physical activity, and other factors that strain the cardiovascular system. The most common cause of coronary artery disease is the arteries' buildup of fatty plaques. These gradual increases in heart-related diseases raised the demand for the cardiac valve to treat heart valve problems. For instance, in October 2024, according to the Centers for Disease Control, a US-based government agency, in 2023, approximately 919,032 people died from cardiovascular disease, accounting for 1 in every 3 deaths. Therefore, the rising incidence of cardiovascular diseases will drive the growth of the cardiac valve industry.

Key Players In The Global Cardiac Valve Market

Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomédica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl

Global Cardiac Valve Market Trends and Insights

Major companies operating in the cardiac valve market are focusing on developing technological advancements such as transfemoral transcatheter mitral valve replacement (TMVR) systems to meet the rising demand for minimally invasive therapies in an aging population with increasing rates of mitral regurgitation. A transfemoral TMVR system uses a collapsible frame and biologic valve leaflets that can be delivered via a catheter through the femoral vein, avoiding open‑heart surgery and allowing for reduced recovery times, lower procedural risk, and better suitability for patients who are ineligible for surgery. For instance, in April 2025, Edwards Lifesciences, a U.S.-based medical device company, received CE Mark approval for its SAPIEN M3 System, the first transcatheter mitral valve replacement therapy delivered via a transfemoral approach. The SAPIEN M3 combines a docking mechanism that first secures the native mitral leaflets and chordae by pulling them inward, creating a stable landing zone, followed by deployment of a bioprosthetic valve both delivered through a steerable 29 F guide sheath. This design enables precise placement, repositioning, and retrieval prior to final deployment, improving procedural safety and expanding treatment to patients unsuitable for surgery or edge‑to‑edge repair.

What Are Latest Mergers And Acquisitions In The Cardiac Valve Market?

In July 2024, Edwards Lifesciences, a US-based provider of structural heart devices, acquired JenaValve Technology for an upfront $500 million, with up to $445 million in contingent payments. Through this acquisition, Edwards aims to expand its cardiac valve portfolio and strengthen its position in treating aortic regurgitation by integrating JenaValve’s Trilogy transcatheter heart valve system. JenaValve Technology is a US-based medical device company that develops transcatheter heart valve systems for the treatment of aortic regurgitation.

Regional Outlook

North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cardiac Valve Market?

The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.